Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients

NCT03829852 · clinicaltrials.gov ↗

COMPLETED

Status

716

Enrollment

OTHER_GOV

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Regorafenib

Sponsor

Taipei Veterans General Hospital, Taiwan

Collaborators

[object Object]
[object Object]